Ben van Ravenzwaay
Ben van Ravenzwaay publishes mostly in Molecular Biology, Health, Toxicology and Mutagenesis and Dermatology, on topics such as Effects and risks of endocrine disrupting chemicals, Metabolomics and Mass Spectrometry Studies and Contact Dermatitis and Allergies.
- World rank
- #945,797 of 7,710,434 ranked researchers
- Rank in Germany
- #46,597 of 364,343
- Works
- 86
- Citations
- 3.5k
- Citations per work
- 40.6
What does Ben van Ravenzwaay research?
Ben van Ravenzwaay's work is mostly in Biochemistry, Genetics and Molecular Biology (19%), Environmental Science (13%), Medicine (8%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else4451.7%
- Life Sciences2023.2%
- Physical Sciences1112.6%
- Environmental Science1112.6%
- Health Sciences1112.5%
- Medicine78.2%
- Veterinary44.3%
- 1Molecular Biology15% of their works
- 2Health, Toxicology and Mutagenesis13% of their works
- 3Dermatology8% of their works
- 4Small Animals4% of their works
- 5Cancer Research4% of their works
- 6Pharmacology4% of their works
Research topics
- Effects and risks of endocrine disrupting chemicals
- Metabolomics and Mass Spectrometry Studies
- Contact Dermatitis and Allergies
- Animal testing and alternatives
- Carcinogens and Genotoxicity Assessment
- Advancements in Transdermal Drug Delivery
- Computational Drug Discovery Methods
- Inhalation and Respiratory Drug Delivery
Which keywords describe Ben van Ravenzwaay's research?
The keywords of their largest research topics: Risk Assessment, Bisphenol A, Endocrine-Disrupting Chemicals, Mass Spectrometry, Metabolomics, Contact Allergy, Skin Sensitization and Animal Research Reporting.
- Inhaler Devices
- Solid Lipid Nanoparticles
- Microneedles
- Comet Assay
- ARRIVE Guidelines
- Contact Allergy
- Mass Spectrometry
- Bisphenol A
- Risk Assessment
- Endocrine-Disrupting Chemicals
- Metabolomics
- Skin Sensitization
- Animal Research Reporting
- Genotoxicity Testing
- Molecular Docking
- Virtual Screening
- Pulmonary Drug Delivery
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Risk Assessment182 topics
- Bisphenol A151 topic
- Endocrine-Disrupting Chemicals151 topic
- Mass Spectrometry111 topic
- Metabolomics111 topic
- Contact Allergy101 topic
- Skin Sensitization101 topic
- ARRIVE Guidelines91 topic
- Animal Research Reporting91 topic
- Comet Assay81 topic
- Genotoxicity Testing81 topic
- Microneedles71 topic
- Molecular Docking71 topic
- Solid Lipid Nanoparticles71 topic
- Virtual Screening71 topic
- Inhaler Devices61 topic
- Pulmonary Drug Delivery61 topic
Where does Ben van Ravenzwaay work?
Ben van Ravenzwaay's main affiliation in the publication record is BASF (Germany), Germany.
How many publications and citations does Ben van Ravenzwaay have?
OpenAlex counts 86 works and 3,494 citations for Ben van Ravenzwaay, an h-index of 31, ranking #945,797 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Ben van Ravenzwaay. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.